• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices

Dune Medical Devices Inc.

Dune Medical launches first-in-man Smart Biopsy trial

March 26, 2019 By Fink Densford

Dune Medical Devices said today that it launched a first-in-man trial of its Smart Biopsy device, touting that the first patients in the trial have already been treated. The first-in-man cases were performed by Dr. Noemi Weissenberg of Kfar Saba, Israel’s Meir Medical Center, the Alpharetta, Ga.-based company said. Dune Medical’s Smart Biopsy system is […]

Filed Under: Clinical Trials, Diagnostics Tagged With: Dune Medical Devices Inc.

Dune Medical debuts waste-saving surgical probe

July 11, 2018 By Nancy Crotti

Dune Medical Devices has designed a reposable version of its MarginProbe radiofrequency spectropscopy device, which can help surgeons identify remaining cancer cells in real time during a lumpectomy. The updated MarginProbe has a  reusable cable and handle and a single-use attachable probe. It has the potential to reduce waste burden of the MarginProbe up to […]

Filed Under: Radiosurgery/Radiation therapy, Surgical Tagged With: Dune Medical Devices Inc.

OptiScan taps ex-Hansen Medical chief Vance for CEO | Personnel Moves, May 23, 2018

May 23, 2018 By Brad Perriello

OptiScan taps ex-Hansen Medical chief Vance for CEO OptiScan Biomedical tapped former Myoscience and Hansen Medical chief Cary Vance to be its new CEO, replacing interim head William Mince. “I am excited to join OptiScan at this pivotal point in the company’s growth. I believe that the cutting-edge OptiScanner diagnostic system provides a unique platform […]

Filed Under: Wall Street Beat Tagged With: Clinical Innovations, Dune Medical Devices Inc., Globus Medical, OMNIlife Science Inc., OptiScan, Personnel Moves, SetPoint Medical, Strata Skin Sciences, TrueVision Systems

Dune Medical relocates US HQ to Atlanta

August 14, 2017 By Fink Densford

Dune Medical Devices said today it is relocating its US headquarters to Alpharetta, Ga., near Atlanta, from Paoli, Penn. as the company looks to expand its portfolio and improve uptake and reimbursement for its MarginProbe device. The MarginProbe is a breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries, the […]

Filed Under: Business/Financial News Tagged With: Dune Medical Devices Inc.

Dune Medical raises $12m to expand MarginProbe footprint

July 6, 2017 By Brad Perriello

Dune Medical Devices said today that it raised another $12 million it plans to use to expand the indications for the radiofrequency spectroscopy technology used in its MarginProbe cancer detection device. Alpharetta, Ga.- and Caesarea, Israel-based Dune said the $12.3 million round was led by Canepa Healthcare, ATON Partners and the Kraft Group. Dune said it plans […]

Filed Under: Funding Roundup, Imaging, Oncology, Wall Street Beat, Women's Health Tagged With: Dune Medical Devices Inc.

Titan Medical CEO Hargrove is out | Personnel Moves, Oct. 11, 2016

October 11, 2016 By Brad Perriello

Titan Medical CEO Hargrove is out Titan Medical (CVE:TMD) said today that it’s looking for a new CEO after the resignation of John Hargrove as it looks to get back on track with the development program for its Sport robot-assisted surgery platform. Toronto-based Titan said board member John Barker is slated to fill Hargrove’s shoes on […]

Pages: Page 1 Page 2 Page 3 Page 4 Page 5

Filed Under: Business/Financial News Tagged With: AlterG, Boston Scientific, BrainChip Holdings, Dune Medical Devices Inc., Personnel Moves, titanmedical

Dune Medical lands $3.4m EU grant

August 23, 2016 By Fink Densford

Dune Medical Devices said today it won a $3.4 million (EU €3 million) European Union Horizon 2020 research grant. The company said it is 1 of 65 companies selected to receive funding from the $91 billion (EU €80 billion) 7-year program aiming to “secure Europe’s global competitiveness.” “This 3 million euro grant will expedite bringing our […]

Filed Under: Business/Financial News, Diagnostics, Oncology Tagged With: Dune Medical Devices Inc.

U.K. launches study of Dune Medical’s MarginProbe breast cancer device

June 24, 2016 By Brad Perriello

Dune Medical Devices said this week that the U.K.’s National Health Service is launching a study of its MarginProbe device, which is designed to spot cancerous cells on the margins of breast tumors. Paoli, Pa.-based Dune said the NHS’s National Institute of Health Research arm is funding a study to see whether MarginProbe reduces the need for further re-excision […]

Filed Under: Clinical Trials, Oncology, Women's Health Tagged With: Dune Medical Devices Inc.

FDA OKs improved MarginProbe device from Dune Medical

March 23, 2016 By Fink Densford

Dune Medical Devices said today it won pre-market approval from the FDA for modifications to its MarginProbe breast cancer surgical device designed for real-time detection of cancer in breast conserving surgeries. Modifications to the Paoli, Penn.-based company’s device were made to conform to recent changes in the European Union’s Restriction of Hazardous Substances requirements, Dune […]

Filed Under: Food & Drug Administration (FDA), Pre-Market Approval (PMA), Regulatory/Compliance, Women's Health Tagged With: Dune Medical Devices Inc.

Fonar taps MR scan inventor and founder’s son as CEO | Personnel Moves

February 10, 2016 By Fink Densford

Fonar Corp (NSDQ:FONR) said yesterday it named Timothy Damadian, son of magnetic resonance scanning inventor and company founder Dr. Raymond Damadian, as its new president and CEO. The younger Damadian worked with Fonar for 16 years, eventually becoming veep of operations. He formed Fonar subsidiary Health Management Corporation of America, which manages medial and diagnostic […]

Filed Under: Business/Financial News Tagged With: Abiomed, Admedus Ltd., ALR Technologies Inc., Baxter, C.R. Bard, Cordis Corp., Dune Medical Devices Inc., Fonar Corp., Getinge, Insulet, Keystone Technologies, Maquet Cardiovascular LLC, Medtronic, Personnel Moves, Prism Medical, Turnpoint Medical, Vascular Pathways Inc., Vestagen

Dune Medical secures $14M for breast cancer detection

June 26, 2014 By Arezu Sarvestani Leave a Comment

Dune Medical secures $21M for breast cancer detection

Israeli imaging systems maker Dune Medical Devices touted the successful raise of $14 million in equity financing, looking to secure another $7 million before October to support its commercialization efforts.

Filed Under: Funding Roundup, News Well Tagged With: Breast Cancer, Dune Medical Devices Inc.

  • Page 1
  • Page 2
  • Go to Next Page »

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy